Robert J. Bertolini

Of 159 filings, 139 are sales at Charles River Laboratories International, Inc., where Robert J. Bertolini sits as Director. They are small: EUR 3,888,648 in total, a median of EUR 11,769. The largest reaches EUR 1,123,433 (February 13, 2020), ahead of EUR 561,111 (May 20, 2020) and EUR 226,970 (March 1, 2017).

The calendar is very uneven. After 1 filing in 2016, the count jumps to 52 in 2017 and 91 in 2018, then 3 in 2019 and 7 in 2020, before falling back to 1 or 2 a year through 2024. Filings are published a median of 1 day after the trade, between May 16, 2016 and May 15, 2024.

The only purchase in the record is outside that company: EUR 444,302 of Bristol Myers Squibb Co stock, on July 31, 2019, which is 1% of market trades. The record adds 13 share grants and 6 option exercises. Trades by Bertolini within 30 days of colleagues at Charles River Laboratories International, Inc. number 139, 139 and 88, every one in the same direction. The colleagues, in the same order: David Ross Smith, James C. Foster and David P. Johst.